Department of Dermatology, Inonu University, Faculty of Medicine, Malatya, Turkey.
Department of Biophysics, Health Sciences University, Faculty of Medicine, Istanbul, Turkey.
Biomed Res Int. 2019 Oct 31;2019:3232015. doi: 10.1155/2019/3232015. eCollection 2019.
Focal hyperhidrosis mostly affects the axillae, hands, feet, and face. For the management, several techniques are used. The aim of this study was to investigate the effects of direct current administration on the hyperhidrosis disease severity scale (HDSS) in patients with axillary hyperhidrosis that have various HDSS scores.
Original article, University Hospital.
Sixty patients with primary axillary hyperhidrosis were inquired about the HDSS scores and the scores were noted at the onset and at the end of the 10th application. One month after the last session, HDSS scores were also inquired. At the end of 1-month follow-up, the patients whose HDSS scores rose after the 10th session were accepted as nonresponder. For the current delivery, a new iontophoresis application module (Sweat CureR) designed by Dr. Karakoc was used.
Direct current application decreased axillary sweat intensity by 70% at both sides, and lowered the HDSS by about 1.5 degree. Major reduction in sweat intensity was in the patients with low HDSS scores (75%). Negative correlation was found between initial HDSS scores and median values of decreased sweat intensity ( = -0.317, = 0.022). Minimal temporary side effects including skin irritation and one or more vesicle formation were inspected in 29 patients and, the permanent punctual pigmentation was observed only in one patient.
Decrease in axillary hyperhidrosis is satisfactory for these patients. Since iontophoresis application has beneficial effect and minimal side effects, it should be recommended to the patients before advanced management or surgical techniques.
局限性多汗症主要影响腋窝、手、脚和面部。对于这种疾病的治疗,有几种技术可以使用。本研究旨在调查直流电治疗对不同严重程度多汗症疾病严重程度评分(HDSS)的腋窝多汗症患者的影响。
原始文章,大学医院。
60 例原发性腋窝多汗症患者询问 HDSS 评分,并在第 10 次治疗开始和结束时记录评分。在最后一次治疗结束后 1 个月,还询问了 HDSS 评分。在 1 个月的随访结束时,对第 10 次治疗后 HDSS 评分升高的患者,将其视为无反应者。目前使用的是 Karakoc 博士设计的新型离子导入应用模块(Sweat CureR)。
直流电治疗使双侧腋窝出汗强度降低了 70%,HDSS 降低了约 1.5 度。低 HDSS 评分患者的出汗强度明显降低(75%)。初始 HDSS 评分与出汗强度降低的中位数呈负相关( = -0.317, = 0.022)。在 29 例患者中观察到轻微的暂时性副作用,包括皮肤刺激和一个或多个水疱形成,仅在 1 例患者中观察到永久性点状色素沉着。
对于这些患者,减少腋窝多汗症是令人满意的。由于离子导入治疗具有良好的疗效和最小的副作用,因此在采用先进的治疗或手术技术之前,应向患者推荐。